Klinikum der Universität München (LMU Klinikum)

Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients (2017) Cosgarea , Zimmer L, Weide B, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, et al. Conference contribution Erratum to: Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial (2017) Achenbach S, Paul JF, Laurent F, Becker HC, Rengo M, Caudron J, Leschka S, et al. Journal article, Erratum Immunological Aspects of intraoperative Radiotherapy in Breast Cancer after breast conserving Surgery (2017) Tiefenthaller A, Brix N, Escudero PM, Kost B, Rack B, Bodungen Von , Weissenbacher T, et al. Conference contribution Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions (2017) Hassel JC, Heinzerling L, Aberle J, Baehr O, Eigentler TK, Grimm MO, Gruenwald V, et al. Journal article Influence of TNF-alpha inhibitors and fumaric acid esters on male fertility in psoriasis patients (2017) Heppt F, Colsman A, Maronna A, Uslu U, Heppt MV, Kiesewetter F, Sticherling M Journal article Interest in tanning beds and sunscreen in German-speaking countries (2017) Kirchberger MC, Kirchberger LF, Eigentler TK, Reinhard R, Berking C, Schuler G, Heinzerling L, Heppt MV Journal article Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial (2017) Achenbach S, Paul JF, Laurent F, Becker HC, Rengo M, Caudron J, Leschka S, et al. Journal article The tanning habits and interest in sunscreen of Google users: what happened in 12 years? (2017) Kirchberger MC, Heppt MV, Eigentler TK, Kirchberger MA, Schuler G, Heinzerling L Journal article Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition (2017) Heppt MV, Heinzerling L, Kaehler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, et al. Journal article Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma (2017) Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kaehler KC, et al. Journal article